3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Sell
13
INVZ Quote, Financials, Valuation and Earnings
Last price:
$0.62
Seasonality move
:
-9.14%
Day range:
$0.59 - $0.66
52-week range:
$0.45 - $3.14
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.49x
P/B ratio:
1.64x
Volume:
2.6M
Avg. volume:
7.3M
1-year change:
-51.71%
Market cap:
$129.7M
Revenue:
$24.3M
EPS (TTM):
-$0.57
Analysts' Opinion
-
Consensus RatingInnoviz Technologies has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $2.49, Innoviz Technologies has an estimated upside of 281.96% from its current price of $0.65.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.25 representing 100% downside risk from its current price of $0.65.
Fair Value
-
According to the consensus of 3 analysts, Innoviz Technologies has 281.96% upside to fair value with a price target of $2.49 per share.
INVZ vs. S&P 500
-
Over the past 5 trading days, Innoviz Technologies has underperformed the S&P 500 by -8.2% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Innoviz Technologies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Innoviz Technologies revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Innoviz Technologies reported revenues of $6M.
Earnings Growth
-
Innoviz Technologies has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Innoviz Technologies reported earnings per share of -$0.11.
Enterprise value:
61.8M
EV / Invested capital:
--
Price / LTM sales:
4.49x
EV / EBIT:
--
EV / Revenue:
2.54x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.76x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$1.2M
Return On Assets:
-55.91%
Net Income Margin (TTM):
-390.46%
Return On Equity:
-83.58%
Return On Invested Capital:
-83.58%
Operating Margin:
-319.38%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $6M | $20.9M | $24.3M | $14.9M | $6M | |
| Gross Profit | -$8.8M | -$11.6M | -$1.2M | -$2.3M | $539K | |
| Operating Income | -$133.3M | -$132.6M | -$101.9M | -$31.8M | -$19.2M | |
| EBITDA | -$125.9M | -$123.4M | -$94.1M | -$27.9M | -$17.7M | |
| Diluted EPS | -$0.94 | -$0.85 | -$0.57 | -$0.18 | -$0.11 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $57.9M | $274.4M | $187.6M | $160.5M | $82.6M | |
| Total Assets | $72.6M | $327.2M | $255.4M | $219.2M | $132M | |
| Current Liabilities | $17.8M | $21.7M | $32.4M | $37.2M | $27.8M | |
| Total Liabilities | $296.3M | $28.4M | $63.4M | $65.9M | $53.1M | |
| Total Equity | -$223.7M | $298.8M | $192M | $153.3M | $78.9M | |
| Total Debt | $2.5M | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$93.4M | -$93.1M | -$77M | -$14M | -$17.8M | |
| Cash From Investing | $125.4M | $1.1M | $75.5M | $10.2M | $15.1M | |
| Cash From Financing | $609K | $61.9M | $224K | -$484K | $55K | |
| Free Cash Flow | -$116M | -$99.6M | -$81.4M | -$14.5M | -$19M | |
INVZ
Sector
Market Cap
$129.7M
$83.2M
Price % of 52-Week High
20.76%
57.6%
Dividend Yield
0%
0%
Shareholder Yield
--
0.8%
1-Year Price Total Return
-51.71%
-20.29%
Beta (5-Year)
--
0.884
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.69
200-day SMA
Sell
Level
$0.91
Bollinger Bands (100)
Sell
Level
0.57 - 1.51
Chaikin Money Flow
Sell
Level
-163.9M
20-day SMA
Sell
Level
$0.69
Relative Strength Index (RSI14)
Sell
Level
35.08
ADX Line
Sell
Level
20.07
Williams %R
Neutral
Level
-59.9441
50-day SMA
Sell
Level
$1.05
MACD (12, 26)
Sell
Level
-0.09
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
66.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-6.3903)
Sell
CA Score
(Annual)
Level (-2.2879)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (4.7586)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.
Stock Forecast FAQ
In the current month, INVZ has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The INVZ average analyst price target in the past 3 months is $2.49.
-
Where Will Innoviz Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Innoviz Technologies share price will rise to $2.49 per share over the next 12 months.
-
What Do Analysts Say About Innoviz Technologies?
Analysts are divided on their view about Innoviz Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Innoviz Technologies is a Sell and believe this share price will drop from its current level to $1.25.
-
What Is Innoviz Technologies's Price Target?
The price target for Innoviz Technologies over the next 1-year time period is forecast to be $2.49 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is INVZ A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Innoviz Technologies is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of INVZ?
You can purchase shares of Innoviz Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Innoviz Technologies shares.
-
What Is The Innoviz Technologies Share Price Today?
Innoviz Technologies was last trading at $0.62 per share. This represents the most recent stock quote for Innoviz Technologies. Yesterday, Innoviz Technologies closed at $0.65 per share.
-
How To Buy Innoviz Technologies Stock Online?
In order to purchase Innoviz Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 19.38% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 12.74% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 3.5% over the past day.
